OncoCyte Corp (OCX) PT Lowered to $0.45 at Needham & Company

April 4, 2023 7:13 AM EDT
Get Alerts OCX Hot Sheet
Price: $3.20 --0%

Rating Summary:
    4 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 9
Join SI Premium – FREE
Needham & Company analyst Mike Matson lowered the price target on OncoCyte Corp (NASDAQ: OCX) to $0.45 (from $1.40) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change